Company Overview of Kimmel Cancer Center
Kimmel Cancer Center engages in the discovery and development of new approaches and strategies to prevent, diagnose, monitor, and cure human cancer. The company focuses in translating the discoveries in the genetics, cell biology biochemistry, structural biology pharmacology, and immunology of cancer into modalities for prevention and treatment. It develops solutions for various types of cancer, including brain tumors, breast, colorectal, esophageal, gastrointestinal, gynecologic, head and neck, hematologic, kidney, liver, lung, melanoma/skin, pancreatic, prostate, stomach, and testicular cancers. The organization was founded in 1991 and is based in Philadelphia, Pennsylvania.
233 South 10th Street
BLSB, Room 1050
Philadelphia, PA 19107
Founded in 1991
Key Executives for Kimmel Cancer Center
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Kimmel Cancer Center, please visit www.kimmelcancercenter.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.